Home Innovation That Matters

Innovation That Matters

Capricor Therapeutics Seeking New Cell Therapy for Deadly Duchenne Disease

New breakthroughs in science, such as gene and cell therapies, give medical researchers potential new pathways to develop treatments for diseases for unmet medical needs. One of those diseases is Duchenne muscular dystrophy (DMD), a genetic disease in which patients lack the protein dystrophin,...

Vivace Therapeutics Banking on Small Molecules for New Cancer Treatments

Vivace Therapeutics co-founder, president and CEO Sofie Qiao, Ph.D., acknowledges that immunotherapy has dominated headlines in discussions of new cancer treatments, but she believes small molecules are still a valuable treatment modality, particularly with new, advanced research tools available for discovering new compounds. “In the...

A Look at Cell Therapy’s Promise in Regenerative Medicine

One of the most promising new technologies to emerge from the biotechnology era is cell therapy. The purpose of cell therapy is to introduce cells into the body to treat a disease or condition. Contrary to popular belief, cell therapy of the type being...

Cancer Prevention Pharmaceuticals Follows Small Molecule Pathway to Find New Therapy for Rare Disease

During the past decade, advances in biologics and generic biosimilars – with their promise of a more targeted disease approach – have grabbed  the headlines and have overshadowed traditional small molecules. Yet, statistics show there are more than 8,000 small molecules in active research...

Cancer Prevention Pharmaceuticals Follows Small Molecule Pathway to Find New Therapy for Rare Disease

During the past decade, advances in biologics and generic biosimilars – with their promise of a more targeted disease approach – have grabbed  the headlines and have overshadowed traditional small molecules. Yet, statistics show there are more than 8,000 small molecules in active research...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Historic Approvals Highlighted at the Second China Innovative Drug Ecosystem Forum...

The recent China Innovative Drug Ecosystem Forum, organized by STA Pharmaceutical, a WuXi AppTec company (WuXi STA), was a resounding success with apt timing...